Impact of Lenalidomide in Management of FL and MZL

Impact of Lenalidomide in Management of FL and MZL
Don Photo

Don
3 years 84 Views
Category:
Description:
Andre Goy, MD, Chairman and Director of the John Theurer Cancer Center (JTCC) at Hackensack University Medical Center and Chief of the Division of Lymphomas discusses how the approval of lenalidomide will impact how follicular lymphoma (FL) and marginal zone lymphoma (MZL) is managed.